Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
Melynda Geurts
• Melynda Geurts, chief operating officer of D.L. Anderson (Dallas, TX), and Roy Fleischmann, MD, medical director of Metroplex Clinical Research Center (Dallas, TX), have both been elected as the newest members of D.L. Anderson's Board of Directors.
Roy Fleischmann
• After serving as head of preclinical development for Medigene AG (Munich, Germany) for the last nine years, Ulrich Moebius will now take on the position of head of preclinical development and project management at MorphoSys (Munich, Germany).
Ulrich Moebius
• The role of business development executive at Penn Pharma's (Wilmington, DE) North American location will be filled by James Knapp, who joins the company after a seven-year tenure at Almac (Craigavon, UK).
James Knapp
• Formerly holding senior positions in professional services and implementation management, William Broucek will now serve in the newly developed position of senior director, professional services, at Velos (Fremont, CA).
• With more than 20 years experience in virology drug development, Sharon Lynn Benoit will now serve as INC Research's (Raleigh, NC) principal strategist of Infectious Disease.
• Applied Clinical Trial's Editorial Advisory Board member and executive director of the Good Clinical Practice Alliance, Europe, Francis P. Crawley, has been selected as the chairman of ICR's (Bourne End, UK) annual spring conference and exhibition working party.
• Of the 12 nominees for this year's European Inventor of the Year award, four come from the pharmaceutical arena: Jurg Zimmermann of Switzerland, Brian Druker of the United States, Yiqing Zhou and his team from China, and Germany's Maria-Regina Kula.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.